HEADER RECEPTOR 15-JUN-11 3ZRB TITLE STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY TITLE 2 RELATED PROGESTERONE RECEPTOR MODULATORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 678-933; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS RECEPTOR, AGONIST, ANTAGONIST EXPDTA X-RAY DIFFRACTION AUTHOR S.J.LUSHER,H.C.A.RAAIJMAKERS,D.VU-PHAM,K.DECHERING,T.WAI LAM, AUTHOR 2 A.R.BROWN,N.M.HAMILTON,O.NIMZ,R.AZEVEDO,R.MCGUIRE,A.OUBRIE,J.DE AUTHOR 3 VLIEG REVDAT 4 08-MAY-24 3ZRB 1 REMARK REVDAT 3 27-DEC-17 3ZRB 1 AUTHOR JRNL REVDAT 2 26-OCT-11 3ZRB 1 JRNL REVDAT 1 17-AUG-11 3ZRB 0 JRNL AUTH S.J.LUSHER,H.C.RAAIJMAKERS,D.VU-PHAM,K.DECHERING,T.W.LAM, JRNL AUTH 2 A.R.BROWN,N.M.HAMILTON,O.NIMZ,R.BOSCH,R.MCGUIRE,A.OUBRIE, JRNL AUTH 3 J.DE VLIEG JRNL TITL STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF JRNL TITL 2 CHEMICALLY RELATED PROGESTERONE RECEPTOR MODULATORS. JRNL REF J. BIOL. CHEM. V. 286 35079 2011 JRNL REFN ESSN 1083-351X JRNL PMID 21849509 JRNL DOI 10.1074/JBC.M111.273029 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 41751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.106 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3063 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 161 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4041 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 226 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.95000 REMARK 3 B22 (A**2) : -0.71000 REMARK 3 B33 (A**2) : -1.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.93000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.146 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.133 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.096 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.870 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4247 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2895 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5753 ; 1.170 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7107 ; 0.807 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 506 ; 5.359 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;33.255 ;24.463 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 794 ;14.023 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;16.365 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 653 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4536 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 809 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2523 ; 0.716 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1003 ; 0.211 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4107 ; 1.307 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1724 ; 2.226 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1645 ; 3.403 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 683 A 1000 REMARK 3 ORIGIN FOR THE GROUP (A): 20.7580 -14.4640 1.7690 REMARK 3 T TENSOR REMARK 3 T11: 0.0755 T22: 0.0108 REMARK 3 T33: 0.0644 T12: 0.0075 REMARK 3 T13: 0.0337 T23: 0.0119 REMARK 3 L TENSOR REMARK 3 L11: 0.8957 L22: 1.7948 REMARK 3 L33: 1.1923 L12: -0.2972 REMARK 3 L13: 0.0501 L23: -0.0943 REMARK 3 S TENSOR REMARK 3 S11: -0.0360 S12: -0.0500 S13: -0.0877 REMARK 3 S21: 0.0887 S22: 0.0688 S23: 0.0644 REMARK 3 S31: -0.0020 S32: -0.0780 S33: -0.0328 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 683 B 1000 REMARK 3 ORIGIN FOR THE GROUP (A): 7.4900 5.2950 32.8650 REMARK 3 T TENSOR REMARK 3 T11: 0.1592 T22: 0.2027 REMARK 3 T33: 0.0931 T12: 0.0122 REMARK 3 T13: 0.0506 T23: 0.0225 REMARK 3 L TENSOR REMARK 3 L11: 1.1694 L22: 1.3882 REMARK 3 L33: 2.6200 L12: -0.5011 REMARK 3 L13: -0.5623 L23: -0.4961 REMARK 3 S TENSOR REMARK 3 S11: 0.1578 S12: 0.1734 S13: 0.1711 REMARK 3 S21: -0.0829 S22: 0.0150 S23: -0.0324 REMARK 3 S31: -0.0764 S32: -0.5069 S33: -0.1729 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZRB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048708. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44010 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 46.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30%POLYETHYLENE GLYCOL 3350, 0.1M REMARK 280 HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.02850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 674 REMARK 465 SER A 675 REMARK 465 HIS A 676 REMARK 465 MET A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 GLN A 682 REMARK 465 LYS A 933 REMARK 465 GLY B 674 REMARK 465 SER B 675 REMARK 465 HIS B 676 REMARK 465 MET B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 GLN B 682 REMARK 465 LYS B 933 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 932 CG CD CE NZ REMARK 470 LYS B 790 CD CE NZ REMARK 470 LYS B 932 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2049 O HOH A 2082 1.96 REMARK 500 O HOH B 2014 O HOH B 2037 2.12 REMARK 500 O HOH A 2023 O HOH A 2024 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 705 27.62 -78.22 REMARK 500 SER A 837 55.11 -99.16 REMARK 500 GLN A 916 -19.73 -143.48 REMARK 500 MET A 924 47.32 -89.08 REMARK 500 THR B 706 31.81 -91.03 REMARK 500 PHE B 794 53.24 -142.19 REMARK 500 SER B 837 54.77 -103.71 REMARK 500 GLN B 916 -13.19 -146.29 REMARK 500 MET B 924 38.61 -86.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OR8 A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ORC B 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1933 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1934 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1935 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1936 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1933 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C7A RELATED DB: PDB REMARK 900 STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEX REMARK 900 RELATED ID: 2W8Y RELATED DB: PDB REMARK 900 RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED REMARK 900 AGONISTIC CONFORMATION REMARK 900 RELATED ID: 1A28 RELATED DB: PDB REMARK 900 HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN REMARK 900 RELATED ID: 1ZUC RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITHTHE REMARK 900 NONSTEROIDAL AGONIST TANAPROGET REMARK 900 RELATED ID: 3ZR7 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY REMARK 900 RELATED PROGESTERONE RECEPTOR MODULATORS REMARK 900 RELATED ID: 1SQN RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUNDNORETHINDRONE REMARK 900 RELATED ID: 1SR7 RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUNDMOMETASONE REMARK 900 FUROATE REMARK 900 RELATED ID: 1E3K RELATED DB: PDB REMARK 900 HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH REMARK 900 THE LIGAND METRIBOLONE (R1881) REMARK 900 RELATED ID: 3ZRA RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY REMARK 900 RELATED PROGESTERONE RECEPTOR MODULATORS DBREF 3ZRB A 678 933 UNP P06401 PRGR_HUMAN 678 933 DBREF 3ZRB B 678 933 UNP P06401 PRGR_HUMAN 678 933 SEQADV 3ZRB GLY A 674 UNP P06401 EXPRESSION TAG SEQADV 3ZRB SER A 675 UNP P06401 EXPRESSION TAG SEQADV 3ZRB HIS A 676 UNP P06401 EXPRESSION TAG SEQADV 3ZRB MET A 677 UNP P06401 EXPRESSION TAG SEQADV 3ZRB GLY B 674 UNP P06401 EXPRESSION TAG SEQADV 3ZRB SER B 675 UNP P06401 EXPRESSION TAG SEQADV 3ZRB HIS B 676 UNP P06401 EXPRESSION TAG SEQADV 3ZRB MET B 677 UNP P06401 EXPRESSION TAG SEQRES 1 A 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 A 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 A 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 A 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 A 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 A 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 A 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 A 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 A 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 A 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 A 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 A 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 A 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 A 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 A 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 A 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 A 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 A 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 A 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 A 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 B 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 B 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 B 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 B 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 B 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 B 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 B 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 B 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 B 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 B 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 B 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 B 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 B 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 B 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 B 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 B 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 B 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 B 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 B 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 B 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS HET OR8 A1000 26 HET SO4 A1933 5 HET GOL A1934 6 HET GOL A1935 6 HET GOL A1936 6 HET ORC B1000 26 HET GOL B1933 6 HETNAM OR8 2-CHLORO-N-[[4-(3,5-DIMETHYLISOXAZOL-4-YL) HETNAM 2 OR8 PHENYL]METHYL]-1,4-DIMETHYL-1H-PYRAZOLE-4-SULFONAMIDE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM ORC (R)-N-[1-[4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL]ETHYL]-3, HETNAM 2 ORC 5-DIMETHYLISOXAZOLE-4-SULFONAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 OR8 C17 H19 CL N4 O3 S FORMUL 4 SO4 O4 S 2- FORMUL 5 GOL 4(C3 H8 O3) FORMUL 8 ORC C18 H21 N3 O4 S FORMUL 10 HOH *226(H2 O) HELIX 1 1 PRO A 685 GLU A 695 1 11 HELIX 2 2 THR A 710 LEU A 736 1 27 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 SER A 772 1 30 HELIX 5 5 ASN A 785 MET A 789 5 5 HELIX 6 6 GLU A 791 GLN A 812 1 22 HELIX 7 7 SER A 814 LEU A 827 1 14 HELIX 8 8 SER A 837 LEU A 858 1 22 HELIX 9 9 GLY A 862 GLN A 897 1 36 HELIX 10 10 GLN A 897 SER A 902 1 6 HELIX 11 11 PRO A 906 ALA A 922 1 17 HELIX 12 12 PRO B 685 GLU B 695 1 11 HELIX 13 13 THR B 710 LEU B 736 1 27 HELIX 14 14 GLY B 738 LEU B 742 5 5 HELIX 15 15 HIS B 743 SER B 772 1 30 HELIX 16 16 ASN B 785 SER B 792 1 8 HELIX 17 17 PHE B 794 GLN B 812 1 19 HELIX 18 18 SER B 814 LEU B 827 1 14 HELIX 19 19 SER B 837 GLN B 860 1 24 HELIX 20 20 GLY B 862 GLN B 897 1 36 HELIX 21 21 GLN B 897 SER B 902 1 6 HELIX 22 22 PRO B 906 ALA B 922 1 17 SHEET 1 AA 2 LEU A 776 ALA A 779 0 SHEET 2 AA 2 LEU A 782 LEU A 784 -1 O LEU A 782 N ALA A 779 SHEET 1 AB 2 THR A 829 ILE A 830 0 SHEET 2 AB 2 LYS A 926 PRO A 927 -1 O LYS A 926 N ILE A 830 SHEET 1 BA 2 LEU B 776 ALA B 779 0 SHEET 2 BA 2 LEU B 782 LEU B 784 -1 O LEU B 782 N ALA B 779 SHEET 1 BB 2 THR B 829 PRO B 831 0 SHEET 2 BB 2 VAL B 925 PRO B 927 -1 O LYS B 926 N ILE B 830 SITE 1 AC1 10 LEU A 715 LEU A 718 ASN A 719 LEU A 721 SITE 2 AC1 10 GLN A 725 MET A 756 MET A 759 MET A 801 SITE 3 AC1 10 CYS A 891 THR A 894 SITE 1 AC2 11 LEU B 715 LEU B 718 ASN B 719 TRP B 755 SITE 2 AC2 11 MET B 756 MET B 759 MET B 801 TYR B 890 SITE 3 AC2 11 CYS B 891 PHE B 905 MET B 909 SITE 1 AC3 9 PRO A 737 GLY A 738 ARG A 740 ASN A 741 SITE 2 AC3 9 HOH A2138 PRO B 737 GLY B 738 ARG B 740 SITE 3 AC3 9 ASN B 741 SITE 1 AC4 5 PRO A 737 GLY A 738 MET A 844 SER A 847 SITE 2 AC4 5 GOL A1936 SITE 1 AC5 7 TYR A 753 THR A 829 HIS A 881 HIS A 888 SITE 2 AC5 7 ILE A 920 HOH A2050 HOH A2114 SITE 1 AC6 5 GOL A1934 HOH A2138 LEU B 687 GLY B 738 SITE 2 AC6 5 SER B 847 SITE 1 AC7 3 TYR B 890 ASN B 893 THR B 894 CRYST1 56.252 64.057 69.691 90.00 96.62 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017777 0.000000 0.002063 0.00000 SCALE2 0.000000 0.015611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014445 0.00000